Reye-like syndrome following treatment with the pantothenic acid antagonist, calcium hopantenate.

AUTOR(ES)

Noda, S

RESUMO

Three senile patients developed fatal acute encephalopathy while receiving calcium hopantenate. The clinical, biochemical, and pathological picture was similar to Reye's syndrome. Calcium hopantenate is a pantothenic acid antagonist. The serum levels of calcium hopantenate were high in coma, and that of pantothenic acid examined in one patient was lowered. Evidence obtained indicated that the Reye-like syndrome might be caused by calcium hopantenate possibly due to the induction of pantothenic acid deficiency.

Documentos Relacionados

• Adult Reye-like syndrome associated with serologic evidence of acute parvovirus B19 infection
• Neonatal presentation of ventricular tachycardia and a Reye-like syndrome episode associated with disturbed mitochondrial energy metabolism
• A calcium antagonist, nifedipine, modifies exercise-induced asthma.
• Reye's Syndrome
• Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders